Repeats of this serum were consistently 3.8 mmol/l, and a re-examination of the original plateau revealed it to have the atypical characteristics. These were not sufficiently marked as to have caused the plateau to be rejected on the initial recording. Similar results have been obtained from time to time using Labtrol and PathotroI (Dade) but not with Q'Pak (Hyland, Travenol Laboratories).
The phenomenon appears to be associated with non-human sera and has not been observed with patients' sera. Presumably a constituent of these sera acts as a solubilizing agent for potassium deposited somewhere in the flame photometer, possibly the atomizer.
Cleaning the flame unit weekly with dilute hypochlorite removes this interference. The presence of a build-up is demonstrated by a steady change upwards in the slope of the Cusum plot using the current batch of horse serum. Further investigations of the phenomenon are precluded by the need to keep the flame photometer serviceable for patients' sera and I am reluctant to allow the build-up to go unchecked.
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